Concepedia

Hongli Li

HL

Statistics

Publications

4

Citations

228

H-Index

4

Active since

2018

Affiliations

Tianjin Beichen Hospital(Current)

Hongli Li is an author at Tianjin Beichen Hospital specializing in autophagy, molecular oncology, and autophagy inhibition.

Publications per year

2018–2023

4

Publications

4

MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1

Xiaoxiao Liu, Yunfei Deng, Yifeng Xu et al. · Journal of Molecular and Cellular Cardiology · 2018 · 94 citations

Life Sciences, Cell Biology, Molecular Biology +17

The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer

Huiya Wang, Xia Wang, Haiyang Zhang et al. · Oncogene · 2021 · 64 citations

Medicine, Cancer Biology, Oncology +17

miR-196b promotes lung cancer cell migration and invasion through the targeting of GATA6

Hongli Li, Chao Feng, Songtao Shi · Oncology Letters · 2018 · 42 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Duvelisib attenuates bleomycin‐induced pulmonary fibrosis via inhibiting the <scp>PI</scp>3<scp>K</scp>/Akt/m<scp>TOR</scp> signalling pathway

Xiaohe Li, Xiaoyang Ma, Jianwei Zhang et al. · Journal of Cellular and Molecular Medicine · 2023 · 28 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

1–4 of 4